View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
 PRESS RELEASE

Teladoc Health to Announce Third Quarter 2025 Financial Results

Teladoc Health to Announce Third Quarter 2025 Financial Results NEW YORK, Oct. 15, 2025 (GLOBE NEWSWIRE) -- Teladoc Health Inc. (NYSE: TDOC), the global leader in virtual care, announced that it will release third quarter 2025 results on Wednesday, October 29, 2025, after the market closes. In conjunction, the company will host a conference call to review results at 5:00 p.m. ET on the same day.  Conference Call Details The conference call can be accessed by dialing 1-833-470-1428 for U.S. participants and using the access code # 609817. For international participants, please visit the f...

Twilio Inc: 1 director

A director at Twilio Inc sold 8,035 shares at 115.000USD and the significance rating of the trade was 69/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly show...

 PRESS RELEASE

Teladoc Health Adds Workplace Safety Capability to its AI-Enabled Clar...

Teladoc Health Adds Workplace Safety Capability to its AI-Enabled Clarity™ Monitoring Solution for Hospitals and Health Systems New capability aims to address the growing threat of workplace violence in healthcare settings, building on the company’s suite of AI-enabled solutions that leverage purpose-built technology to transform care NEW YORK, Oct. 14, 2025 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE: TDOC), the global leader in virtual care, today announced the launch of a new offering to help hospitals and health systems address workplace violence. This is the latest innovation within T...

 PRESS RELEASE

Occidental to Announce Third Quarter Results Monday, November 10, 2025...

Occidental to Announce Third Quarter Results Monday, November 10, 2025; Hold Conference Call Tuesday, November 11, 2025 HOUSTON, Oct. 09, 2025 (GLOBE NEWSWIRE) -- (NYSE: OXY) will announce its third quarter 2025 financial results after close of market on Monday, November 10, 2025, and will hold a conference call to discuss the results on Tuesday, November 11, 2025, at 1 p.m. Eastern/12 p.m. Central. The conference call may be accessed by calling 1-866-871-6512 (international callers dial 1-412-317-5417) or via webcast at Participants may pre-register for the conference call at . Third...

Moody's Ratings says Occidental Petroleum's sale of OxyChem is credit ...

Moody's Ratings (Moody's) said that Occidental Petroleum Corporation's (OXY, Baa3 stable) ratings and outlook are not affected by the sale of its chemical business (OxyChem). The sale is credit positive, with the planned debt reduction, lower leverage and improved credit metrics more than offsetting...

 PRESS RELEASE

Occidental Promotes Richard A. Jackson to Senior Vice President and Ch...

Occidental Promotes Richard A. Jackson to Senior Vice President and Chief Operating Officer HOUSTON, Oct. 02, 2025 (GLOBE NEWSWIRE) -- (NYSE: OXY) announced today that its Board of Directors has promoted Richard A. Jackson to Senior Vice President and Chief Operating Officer, overseeing global oil and gas operations, low-carbon integrated technologies and the midstream and marketing and health, safety and environment functions. He will continue reporting to Vicki Hollub, President and Chief Executive Officer. Jackson was named Senior Vice President and President, U.S. Onshore Resources a...

Chase Tohanczyn ... (+3)
  • Chase Tohanczyn
  • Matthew Weiss
  • Scott Devitt

Now Arriving: September '25 Online Travel Trends

Key Findings:US hotel RevPAR growth averaged -1% Y/Y QTD through August, decelerating ~60bps from 2Q. RevPAR growth has been slightly negative the last three months after flat growth in May and April. Through the first two weeks of September, US hotel RevPAR has continued to stabilize.International

Chase Tohanczyn ... (+3)
  • Chase Tohanczyn
  • Matthew Weiss
  • Scott Devitt

Counting Clicks: August '25 Traffic Trends

Report Overview: Our analysis includes total web visits (desktop and mobile) to U.S. and international web domains, mobile app monthly active users (MAUs), daily active users (DAUs), and total time spent (where applicable). Throughout the report, we display Y/Y changes across each of these key metr

Chase Tohanczyn ... (+3)
  • Chase Tohanczyn
  • Matthew Weiss
  • Scott Devitt

Takeaways from Skift Global Forum 2025

"Building Airbnb's Next Chapter":Brian Chesky, Co-Founder and CEO at AirbnbAirbnb CEO and Co-Founder Brian Chesky addressed Airbnb's lower-than-industry growth rate and shared his plan to reinvigorate growth to the teens-to-twenty percent range. The plan is centered around leveraging AI across the

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights.com Daily Ratings Report: September 11, 2025

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

 PRESS RELEASE

First Commercial Medicare Advantage Plan Provides Payment for ReWalk 7...

First Commercial Medicare Advantage Plan Provides Payment for ReWalk 7 Personal Exoskeleton Medicare Advantage claim processed in less than thirty days Additional progress with traditional Medicare claim approvals has accelerated timelines to payment in 2025 MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, Sept. 09, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd., (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global leader in innovative medical technology to transform the lives of people with physical limitations or disabilities, announced today that it received its first payment from a commercia...

 PRESS RELEASE

Lifeward Achieves CE Mark Approval for the ReWalk 7 Personal Exoskelet...

Lifeward Achieves CE Mark Approval for the ReWalk 7 Personal Exoskeleton Seventh generation of industry-leading ReWalk Exoskeleton is now cleared for commercial launch in the European Union MARLBOROUGH, Mass. and YOKNEAM ILLIT, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd., (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global leader in innovative medical technology to transform the lives of people with physical limitations or disabilities, announced today that the company has received CE mark approval for the ReWalk 7 Personal Exoskeleton, clearing it for commercial sale in Europe....

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights.com Daily Ratings Report: September 3, 2025

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch